Facebook, UW School of Medicine and Public Health Team up on Social Media Research
A partnership between Facebook and the University of Wisconsin School of Medicine and Public Health will explore the relationship between teens’ use of digital technologies and their mental and social health.
The research is part of Facebook’s $1 million commitment to work with academics, experts and partners across the industry to further explore this topic. Dr. Megan Moreno, professor and head of the Social Media and Adolescent Health Research Team (SMAHRT) will lead the project at the School of Medicine and Public Health.
“The research will answer foundational and unanswered questions regarding youth, technology, and well-being and will provide guidelines for healthy family digital use,” said Moreno.
Objectives of the study include understanding the relationship between digital technology use and health and well-being of youth; understanding the role of parents in their children’s use of digital technology and well-being; assessing effects of interventions on health and wellbeing; and understanding real-time links between mood and social-media use behaviors.
The study will begin this fall.
Bruce Klein, MD, Awarded Grant from US Geological Survey
Bruce Klein, MD, was recently awarded a 1-year grant for $49,527 from the United States Geological Survey (USGS) National Wildlife Health Center for his project entitled, "The novel method for assessing vaccines against White Nose Syndrome using a mouse model." The overall goal of this project is to determine vaccine antigens that might be useful in protecting bats against white nose syndrome and to test those antigens in an alternative animal model. Congratulations!
Ryan Coller, MD, MPH, Awarded HRSA Subaward with University of Colorado-Denver
Congratulations to Ryan Coller, MD, MPH, Principal Investigator, and Mary Ehlenbach, MD, Co-Investigator, who were recently awarded a subaward for up to 4 years from the University of Colorado-Denver and the Health Resources and Services Administration (HRSA). This project, worth $75,000 of total costs in Year 1, is under the direction of University of Colorado overall PI Christopher Stille, MD, and is entitled "Children and youth with special health care needs research network programs." The Wisconsin team is leading development of 2 projects for the new National Research Network for Children and Youth with Special Health Care Needs (CYSHCNet).
In the first project, Dr. Coller and his team led a multidisciplinary national expert modified-Delphi panel and series of stakeholder focus groups to identify the top priorities for a new National Research Agenda for Children and Youth with Special Health Care Needs.
The second project, “Assessing Confidence at Times of Increased Vulnerability (ACTIV),” is a multisite study involving UW, Harvard, and UCLA that's led by Dr. Coller's team. The goal of this study is to evaluate the feasibility and acceptability of an innovative health information technology tool to collect repeated measures of caregiver confidence of the health of children with medical complexity over time.
Mario Otto, MD, PhD, Receives St. Baldrick's Research Award
Congratulations to Mario Otto, MD, PhD, who was recently awarded a 2018 Research Award from the St. Baldrick's Foundation. This one-year grant, in the amount of $100,000, will support his project entitled, "Improving anti-cancer immune responses to targeted radionuclide therapy." The goal of this project is to combine molecular-targeted radiotherapy with immunomodulatory agents to facilitate radiation-damage induced anti-tumor immune responses. Other UW investigators include Bryan Bednarz, PHD (Medical Physics) and Jamey Weichert, PhD (Radiology).
Dr. Bruce Klein Awarded NIH/NIAID Grant
Congrats to Bruce Klein, MD, on his recent R01 research grant funding from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH/NIAID). His 4-year, $1.85 million project is entitled, "Lung epithelial cell regulation of immunity to inhaled fungi". Our fragile ecosystem has become increasingly plagued by airborne spores from both old and newly emergent fungi due to the excavation of new land and ever-changing climate. Despite this growing public health challenge, little is known about how lung epithelial cells that line the respiratory mucosa sense and manage these repeated spore challenges with each inhaled breath. This project aims to address that gap in knowledge while identifying new avenues for therapeutically targeting early events designed to optimize mucosal immunity to fungi and lung inflammation and powerful gene editing tools to advance the study of lung epithelial cells by the field.
Dr. Ei Terasawa Receives NIH/NICHD Grant
Ei Terasawa, PhD, was recently awarded a 5-year, $2 million research grant from the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NIH/NICHD) for her project, "Role of neuroestradiol in regulation of the GnRH surge". The overall objective of this proposal is to investigate the regulation of gonadotropin-releasing hormone (GnRH) neurons in the non-human primate. Information obtained from this study will provide a basis for the development of new tools for clinical management of infertility and would lead to a new target for the development of new contraceptive drugs.
Dr. Daniele Gusland Awarded UW Global Health Institute Grant
Congratulations to Daniele Gusland, MD, and her mentors, James Conway, MD, and Dawd Siraj, MD (Department of Medicine), on receiving $25,000 from the University of Wisconsin Global Health Institute for their project, "Etiology and Antimicrobial Resistance Patterns of Neonatal Sepsis in Jimma, Ethiopia (EARNEST)". The team aims to identify the most common organisms responsible for neonatal bacterial infection and estimate the likelihood of successful treatment of these organisms based on their resistance rates to first line antibiotics. This will be done via a 12-month prospective study of 1,000 neonates and young infants admitted to Jimma University Hospital with possible serious bacterial infection (as defined by the WHO danger signs, including poor feeding, seizures, fever, lethargy, hypothermia, tachypnea, and increased work of breathing).
Dr. Mary Ehlenbach Receives Inaugural Paster Family Foundation Award
Mary Ehlenbach, MD, (Assistant Professor [CHS], Division of Hospital Medicine) was selected as the inaugural recipient of the Paster Family Foundation Innovation Award. This award is given for a project, system improvement or initiative that has made a difference in human health and/or the lives of patients and their families.
Dr. Ehlenbach was chosen for the award for her work to design and implement the Pediatric Complex Care Program at American Family Children' Hospital, which has improved the health and touched the lives of over 300 children. She will receive the award on November 9, 2018, at a dinner for the Middleton Society, the SMPH's philanthropic member society; she intends to use the prize money to further develop the program through professional development for team members, wellness activities, or equipment or technology.
Dr. Balasubramaniam Receives UW Foundation Grant
Congratulations to Vivek Balasubramaniam, MD, and Kim Whitmore, PhD, RN (Nursing), on receipt of ~$48,000 in funding via the UW Foundation for their project, "eHomeCare - an innovative health care delivery support system for homecare nurses". This project aims to increase access to an evidence-based, nursing-driven educational program by leveraging a web-based, mobile training platform to develop eHomeCare. This innovative health care delivery support system will provide homecare nurses with comprehensive information about the care of children with a tracheostomy and/or ventilator that can be used as an initial training, annual review, as well as an on-going resource to support critical thinking in the home and community setting.
Dr. Bikash Pattnaik Awarded 2-Year Research Grant
Bikash Pattnaik, PhD, was recently awarded a 2-year research grant of $250,000 from Ateres Avigail in support of his project, "Restoration of potassium channel function using mouse models of Lebers Congenital Amaurosis (LCA16) as a means to treat retinal channelopathies." This project will use mouse models to deliver lentiviral and adenoviral gene-therapy during early, middle and late stages of development targeted to retina pigment epithelium (RPE) apical processes. This study is the first of several steps aimed at developing preventative approaches to treat blindness in LCA16 and testing the role of precision medicine therapeutics.